Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of DA9601 for acute and chronic gastritis has completed, with the study aiming to identify the optim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• DA9601

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Acute Gastritis, Chronic Gastritis | Phase 2 | Status: COMPLETED